Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Intracellular Nucleic Acid Sensors and Autoimmunity
2011 StandoutNobel
Optical coherence tomography angiography
2017 Standout
Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis
2007
Glutamate uptake
2001 Standout
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
2004 Standout
Neurocysticercosis: An Update
1988
Taenia solium cysticercosis
2003 Standout
Fabry disease: Immunocytochemical characterization of neuronal involvement
1992
Overview of the biology of type I interferons
2010
Enzyme Replacement Therapy in Fabry Disease
2001 Standout
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
2006
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
The Pathogenesis of the Antiphospholipid Syndrome
2013
Targeting BAFF in autoimmunity
2010
Validity of the Brief Pain Inventory for Use in Documenting the Outcomes of Patients With Noncancer Pain
2004 Standout
Systemic Lupus Erythematosus
2011 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Adalimumab in the therapy of uveitis in childhood
2006
Regulation of type I interferon responses
2013 Standout
Anti–tumor necrosis factor-α therapy in uveitis
2015
New approaches for managing antiphospholipid syndrome
2009
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
2020 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males
2001
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
2006 Standout
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
2011
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease
2017
Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.
1992
Guidelines for the Primary Prevention of Stroke
2014 Standout
B Cell and BAFF Dependence of IFN-α–Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice
2011
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages
2010
Cysticercosis Cerebri Review of 127 Cases
1982
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Works of Philip Kahn being referenced
Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain
1973
Interferon‐α treatment of female (NZW × BXSB)F1 mice mimics some but not all features associated with the Yaa mutation
2009
Prevention of murine antiphospholipid syndrome by BAFF blockade
2008
Favorable Response to High-Dose Infliximab for Refractory Childhood Uveitis
2006
Cysticercosis of the central nervous system with amyotrophic lateral sclerosis: case report and review of the literature
1972